Description

Kadcyla is a medication used in the treatment of certain types of breast cancer. It is an antibody-drug conjugate that combines a targeted therapy with a chemotherapy agent to deliver treatment directly to cancer cells.

Interpreter Notes

Interpreters should be aware that Kadcyla may be referred to by its generic name, trastuzumab emtansine, in some contexts. It is important to maintain a formal register and ensure that patients understand the specific use of this medication in their treatment plan. Avoid using colloquial terms or abbreviations that may confuse patients.

Example Sentences

EN: The oncologist recommended Kadcyla as part of the treatment plan for the patient.

ES: El oncólogo recomendó Kadcyla como parte del plan de tratamiento para el paciente.

Common Interpreter Mistakes

Confusing Kadcyla with other cancer medications; using informal language instead of clinical terminology; misidentifying the drug's mechanism of action.